» Articles » PMID: 38542726

Use of Complementary and Alternative Medicine in Patients with Rare Bone Diseases and Osteoporosis

Overview
Journal Nutrients
Date 2024 Mar 28
PMID 38542726
Authors
Affiliations
Soon will be listed here.
Abstract

(1) Background: The use of complementary and alternative medicine (CAM) has seen a notable increase in popularity. However, there is an absence of data regarding the prevalence of CAM use in patients with rare bone diseases (RBDs). (2) Methods: This monocentric, cross-sectional study was carried out in a reference hospital for RBDs. RBD patients included individuals with osteogenesis imperfecta, hypophosphatasia and X-linked hypophosphatemia, and their data were compared with those of patients with osteoporosis (OPO) and of healthy controls (CON). This study utilized the German version (I-CAM-G) of the I-CAM questionnaire. (3) Results: This study comprised 50 RBD patients [mean age (SD) of 48.8 (±15.9), 26% male], 51 OPO patients [66.6 (±10.0), 9.8% male] and 52 controls [50.8 (±16.3), 26.9% male]. Treatments by naturopaths/healers were more prevalent in the RBD group (11.4%) compared with OPO (0%) and CON (5.8%) ( = 0.06). More than half of the OPO (60.8%) and CON (63.5%) patients and 46% of the RBD patients reported vitamin/mineral intake within the past 12 months ( = 0.16). Individuals with tertiary education had a significantly higher odds ratio of 2.64 (95% CI: 1.04-6.70, = 0.04) for visiting any CAM provider. Further, OPO patients were significantly less likely to use self-help techniques compared with the CON group (OR = 0.42, 95% CI: 0.19-0.95; = 0.04). (4) Conclusions: Herbal medicine, vitamin and mineral supplements, and self-help techniques were the most common forms of CAM reported by patients with RBDs. However, the use of CAM was generally low.

Citing Articles

Nutritional Behavior of Patients with Bone Diseases: A Cross-Sectional Study from Austria.

Kraus D, Medibach A, Behanova M, Kocijan A, Haschka J, Zwerina J Nutrients. 2024; 16(12).

PMID: 38931274 PMC: 11206606. DOI: 10.3390/nu16121920.

References
1.
Zhang N, Han T, Huang B, Rahman K, Jiang Y, Xu H . Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery. J Ethnopharmacol. 2016; 189:61-80. DOI: 10.1016/j.jep.2016.05.025. View

2.
Kishnani P, Rockman-Greenberg C, Rauch F, Bhatti M, Moseley S, Denker A . Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia. Bone. 2018; 121:149-162. DOI: 10.1016/j.bone.2018.12.011. View

3.
Raimann A, Mindler G, Kocijan R, Bekes K, Zwerina J, Haeusler G . Multidisciplinary patient care in X-linked hypophosphatemic rickets: one challenge, many perspectives. Wien Med Wochenschr. 2020; 170(5-6):116-123. PMC: 7098922. DOI: 10.1007/s10354-019-00732-2. View

4.
Huston P, McFarlane B . Health benefits of tai chi: What is the evidence?. Can Fam Physician. 2017; 62(11):881-890. PMC: 9844554. View

5.
Stanarevic Katavic S . Health information behaviour of rare disease patients: seeking, finding and sharing health information. Health Info Libr J. 2019; 36(4):341-356. DOI: 10.1111/hir.12261. View